Patents by Inventor Yuichiro Kishi
Yuichiro Kishi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 8604162Abstract: Provided are isolated collectin (CL-L2s) genes including a base sequence set out in SEQ ID NO: 1, 3, 5, 7, 9, 12, 36, 38 or 40 relating to a novel collectin which are expected to exhibit an antibacterial activity, an antiviral activity and the like particularly in a human body; and isolated collectin proteins including an amino acid sequence set out in SEQ ID NO: 2, 4, 6, 8, 10, 13, 37, 39 or 41 and derivatives and fragments thereof.Type: GrantFiled: June 14, 2011Date of Patent: December 10, 2013Assignee: Fuso Pharmaceutical Industries, Ltd.Inventors: Nobutaka Wakamiya, Katsuki Ohtani, Takashi Sakamoto, Yuichiro Kishi
-
Publication number: 20130150565Abstract: Provided are isolated collectin (CL-L2s) genes including a base sequence set out in SEQ ID NO: 1, 3, 5, 7, 9, 12, 36, 38 or 40 relating to a novel collectin which are expected to exhibit an antibacterial activity, an antiviral activity and the like particularly in a human body; and isolated collectin proteins including an amino acid sequence set out in SEQ ID NO: 2, 4, 6, 8, 10, 13, 37, 39 or 41 and derivatives and fragments thereof.Type: ApplicationFiled: June 14, 2011Publication date: June 13, 2013Applicant: Fuso Pharmaceutical Industries, Ltd.Inventors: Nobutaka Wakamiya, Katsuki Ohtani, Takashi Sakamoto, Yuichiro Kishi
-
Publication number: 20120015400Abstract: Disclosed is the novel hCL-K1 polypeptide which offers collectin activity. This polypeptide consists of consecutive 271 amino acids set out in SEQ ID NO: 2 and does not bind to both maltose and N-acetylgalactosamine.Type: ApplicationFiled: April 15, 2011Publication date: January 19, 2012Applicants: ASAHIKAWA MEDICAL COLLEGE, FUSO PHARMACEUTICAL INDUSTRIES, LTD.Inventors: Nobutaka Wakamiya, Katsuki Otani, Takashi Sakamoto, Yuichiro Kishi, Hiroyuki Keshi, Aya Keshi
-
Patent number: 7985833Abstract: Provided are isolated collectin (CL-L2s) genes including a base sequence set out in SEQ ID NO: 1, 3, 5, 7, 9, 12, 36, 38 or 40 relating to a novel collectin which are expected to exhibit an antibacterial activity, an antiviral activity and the like particularly in a human body; and isolated collectin proteins including an amino acid sequence set out in SEQ ID NO: 2, 4, 6, 8, 10, 13, 37, 39 or 41 and derivatives and fragments thereof.Type: GrantFiled: December 12, 2008Date of Patent: July 26, 2011Assignee: Fuso Pharmaceutical Industries, Ltd.Inventors: Nobutaka Wakamiya, Hiroyuki Keshi, Katsuki Ohtani, Takashi Sakamoto, Yuichiro Kishi
-
Publication number: 20090305341Abstract: Disclosed is the novel hCL-K1 polypeptide which offer collectin activity. This polypeptide consists of consecutive 271 amino acids set out in SEQ ID NO: 2 and does not bind to both maltose and N-acetylgalactosamine.Type: ApplicationFiled: April 5, 2007Publication date: December 10, 2009Applicants: FUSO PHARMACEUTICAL INDUSTRIES, LTD, ASAHIKAWA MEDICAL COLLEGEInventors: Nobutaka Wakamiya, Katsuki Otani, Takashi Sakamoto, Yuichiro Kishi, Hiroyuki Keshi, Aya Keshi
-
Publication number: 20090275740Abstract: Provided are isolated collectin (CL-L2s) genes including a base sequence set out in SEQ ID NO: 1, 3, 5, 7, 9, 12, 36, 38 or 40 relating to a novel collectin which are expected to exhibit an antibacterial activity, an antiviral activity and the like particularly in a human body; and isolated collectin proteins including an amino acid sequence set out in SEQ ID NO: 2, 4, 6, 8, 10, 13, 37, 39 or 41 and derivatives and fragments thereof.Type: ApplicationFiled: December 12, 2008Publication date: November 5, 2009Applicant: FUSO PHARMACEUTICAL INDUSTRIES, LTD.Inventors: Nobutaka Wakamiya, Hiroyuki Keshi, Katsuki Ohtani, Takashi Sakamoto, Yuichiro Kishi
-
Publication number: 20090048165Abstract: Disclosed are anti-HIV agents which comprise a mannose binding protein (MBP) as an active component and are useful for effectively inhibiting progress of diseases state in and useful in therapy for individuals infected with human immunodeficiency virus (HIV). Also disclosed are a method for evaluating an anti-HIV activity of MBP comprising the step of culturing HIV infected cells under the presence of MBP.Type: ApplicationFiled: July 8, 2008Publication date: February 19, 2009Applicant: FUSO PHARMACEUTICAL INDUSTRIES, LTD.Inventors: Nobutaka Wakamiya, Katsuki Ohtani, Takashi Sakamoto, Hiroyuki Keshi, Yuichiro Kishi
-
Publication number: 20070191265Abstract: Disclosed are anti-HIV agents which comprise a mannose binding protein (MBP) as an active component and are useful for effectively inhibiting progress of diseases state in and useful in therapy for individuals infected with human immunodeficiency virus (HIV). Also disclosed are a method for evaluating an anti-HIV activity of MBP comprising the step of culturing HIV infected cells under the presence of MBP.Type: ApplicationFiled: March 27, 2007Publication date: August 16, 2007Applicant: FUSO PHARMACEUTICAL INDUSTRIES, LTD.Inventors: Nobutaka Wakamiya, Katsuki Ohtani, Takashi Sakamoto, Hiroyuki Keshi, Yuichiro Kishi
-
Publication number: 20070190652Abstract: Disclosed are anti-HIV agents which comprise a mannose binding protein (MBP) as an active component and are useful for effectively inhibiting progress of diseases state in and useful in therapy for individuals infected with human immunodeficiency virus (HIV). Also disclosed are a method for evaluating an anti-HIV activity of MBP comprising the step of culturing HIV infected cells under the presence of MBP.Type: ApplicationFiled: March 27, 2007Publication date: August 16, 2007Applicant: FUSO PHARMACEUTICAL INDUSTRIES, LTD.Inventors: Nobutaka Wakamiya, Katsuki Ohtani, Takashi Sakamoto, Hiroyuki Keshi, Yuichiro Kishi
-
Publication number: 20070184477Abstract: Disclosed are anti-HIV agents which comprise a mannose binding protein (MBP) as an active component and are useful for effectively inhibiting progress of diseases state in and useful in therapy for individuals infected with human immunodeficiency virus (HIV). Also disclosed are a method for evaluating an anti-HIV activity of MBP comprising the step of culturing HIV infected cells under the presence of MBP.Type: ApplicationFiled: March 27, 2007Publication date: August 9, 2007Applicant: FUSO PHARMACEUTICAL INDUSTRIES, LTD.Inventors: Nobutaka Wakamiya, Katsuki Ohtani, Takashi Sakamoto, Hiroyuki Keshi, Yuichiro Kishi
-
Publication number: 20030158382Abstract: Provided are isolated collectin (CL-L2s) genes including a base sequence set out in SEQ ID NO: 1, 3, 5, 7, 9, 12, 36, 38 or 40 relating to a novel collectin which are expected to exhibit an antibacterial activity, an antiviral activity and the like particularly in a human body; and isolated collectin proteins including an amino acid sequence set out in SEQ ID NO: 2, 4, 6, 8, 10, 13, 37, 39 or 41 and derivatives and fragments thereof.Type: ApplicationFiled: March 19, 2003Publication date: August 21, 2003Inventors: Nobutaka Wakamiya, Hiroyuki Keshi, Katsuki Ohtani, Takashi Sakamoto, Yuichiro Kishi
-
Patent number: 6130086Abstract: The present invention aims to provide a medium composition for in vitro fertilization, in particular, a composition usable in the culture of ova or early embryos which are fertilized eggs, the preparation or culture of sperm, and the pre-treatment of ova or sperm.The composition comprises, as its essential components, L-phenylalanine, L-tryptophan, L-lysine, L-threonine, L-valine, L-methionine, L-isoleucine, L-leucine, L-proline, glycine, L-alanine, L-tyrosine, L-histidine, L-arginine, L-taurine, L-aspartic acid, L-serine, L-asparagine, L-glutamic acid, L-glutamine and L-cystine, provided that at least a part of the L-cystine may be replaced by L-cysteine.Type: GrantFiled: March 2, 1998Date of Patent: October 10, 2000Assignee: Fuso Pharmaceutical Industries, Ltd.Inventors: Teruki Nakazawa, Hiromasa Araki, Yuichiro Kishi, Sanji Shinoda, Moriyuki Yamada, Kazutomo Ohashi
-
Patent number: 5824474Abstract: A method of detecting a nucleic acid which comprises bringing a solid carrier suspected to carry or contain a nucleic acid into contact with a polyamine to which a label capable of generating a detectable signal or a precursor thereof is bound, to form a complex between said nucleic acid and said polyamine, said precursor converting into said label, if used, removing the polyamine which has not formed any complex before or after the conversion of said precursor and then detecting said label.Type: GrantFiled: February 8, 1996Date of Patent: October 20, 1998Assignee: Fuso Pharmaceutical Industries, Ltd.Inventors: Akio Matsuhisa, Kiyotaka Shiba, Yoshikazu Mikawa, Yuichiro Kishi